Skip to content

Evaluation of tissue-engineered hair follicles in hair loss

Evaluation the transplatation of tissue-engineered skin containing hair follicles in androgenetic alopecia; a phase 1 clinical trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20080901001159N32
Enrollment
5
Registered
2021-03-09
Start date
2021-09-23
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia. Androgenic alopecia

Interventions

Intervention group: Tissue engineered skin in 3 cm diameter containing 100 hair follicles, single session engrafment.

Sponsors

Skin and Stem cell Research Center of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
25 Years to No maximum

Inclusion criteria

Inclusion criteria: Hamilton scaling male pattern hair loss more than 3

Exclusion criteria

Exclusion criteria: History of malignancy Known chronic disease Systemic or local active infection Histroy of cell therapy or hair transplantation Viral infections (HBV,HIV ? HCV) History of allergies and sensitivities Patients with contact dermatitis, psoriasis, itching or dry skin Mood disorders, depression, or neuropathy Anti coagulative drugs Hypo/ hyperthyroidism

Design outcomes

Primary

MeasureTime frame
Safety. Timepoint: Intervention start date up to 6 months. Method of measurement: Medical history and physical examination.

Secondary

MeasureTime frame
Number of formed hairs. Timepoint: Before intervention, every 4 weeks up to 6 months. Method of measurement: Trichogram.;Thickness of formed hairs. Timepoint: Before intervention, every 4 weeks up to 6 months. Method of measurement: Trichogram.;Density of formed hairs. Timepoint: Before intervention, every 4 weeks up to 6 months. Method of measurement: Trichogram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Bajouri

Skin and Stem Cells Research Center of Tehran University of Medical Sciences

bajouri.md@gmail.com+98 21 2356 2173

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026